Topical administration of adrenergic receptor pharmaceutics and nerve growth factor

Review, Article English OPEN
Steinle, Jena J (2010)
  • Publisher: Dove Medical Press
  • Journal: Clinical Ophthalmology (Auckland, N.Z.), volume 4, pages 605-610 (issn: 1177-5467, eissn: 1177-5483)
  • Related identifiers: pmc: PMC2909889, doi: 10.2147/OPTH.S10992
  • Subject: RE1-994 | Clinical Ophthalmology | cornea | glaucoma | α-adrenergic receptor agents | NGF | retina | Review | β-adrenergic receptor agents | Ophthalmology
    mesheuropmc: genetic structures | sense organs | eye diseases | nervous system

Jena J SteinleDepartments of Ophthalmology and Anatomy and Neurobiology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN 38163, USAAbstract: Topical application of nerve growth factor (NGF) and adrenergic receptor pharmaceutics are currently in use for corneal ulcers and glaucoma. A recent interest in the neuroprotective abilities of NGF has led to a renewed interest in NGF as a therapeutic for retinal and choroidal diseases. NGF can promote cell proliferation through actions of the TrkA receptor or promote apoptosis through receptor p75NTR. This understanding has led to novel interest in the role of NGF for diseases of the posterior eye. The role of β-adrenergic receptor agonists and antagonists for treatments of glaucoma, diabetic retinopathy, and their potential mechanisms of action, are still under investigation. This review discusses the current knowledge and applications of topical NGF and adrenergic receptor drugs for ocular disease.Keywords: NGF, β-adrenergic receptor agents, α-adrenergic receptor agents, retina, cornea, glaucoma
  • References (51)
    51 references, page 1 of 6

    1. Dechant G, Neumann H. Neurotrophins. Adv Exp Med Biol. 2002; 513:303-334.

    2. Cowan WM, Hamburger V, Levi-Montalcini R. The path to the discovery of nerve growth factor. Annu Rev Neurosci. 2001;24:551-600.

    3. Levi-Montalcini R, Angeletti PU. Nerve growth factor. Physiol Rev. 1968;48(3):534-569.

    4. de la Rosa EJ, de Pablo F. Cell death in early neural development: beyond the neurotrophic theory. Trends Neurosci. 2000;23(10):454-458.

    5. Hill CE, Jelinek H, Hendry IA, et al. Destruction by anti-NGF of autonomic, sudomotor neurones and subsequent hyperinnervation of the foot pad by sensory fibers. J Neurosci Res. 1988;19:474-482.

    6. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci. 2006;361(1473):1545-564.

    7. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609-642.

    8. Steinle JJ, Granger HJ. Nerve growth factor regulates human choroidal, but not retinal, endothelial cell migration and proliferation. Auton Neurosci. 2003;108(1-2):57-62.

    9. Grajewski AL, Ferrari-Dileo G, Feuer WJ, et al. Beta-adrenergic responsiveness of choroidal vasculature. Ophthalmology. 1991;98(6): 989-995.

    10. Grueb M, Bartz-Schmidt KU, Rohrbach JM. Adrenergic regulation of cAMP/protein kinase A pathway in corneal epithelium and endothelium. Ophthalmic Res. 2008;40(6):322-328.

  • Metrics
    No metrics available
Share - Bookmark